In vivo opioid activity of S-methyl and S-allyl morphinan derivatives
Jolicoeur, F.B.; Ménard, D.; Belleau, B.; Lemaire, S.
Progress in Clinical and Biological Research 328: 49-52
1990
ISSN/ISBN: 0361-7742 PMID: 2154809 Document Number: 361633
Document emailed within 1 workday
Related Documents
Verimer, T.; Long, J.P.; Bhatnagar, R.K.; Koble, D.L.; Cannon, J.G.; Flynn, J.R.; Goodale, D.B.; Arnerić, S.P. 1981: Dopamine receptor stimulating activity of 5-hydroxy-6-methyl-2-aminotetralin derivatives Archives Internationales de Pharmacodynamie et de Therapie 250(2): 221-241Nardi, D.; Motta, G.; Tajana, A.; Catto, A.; Cazzulani, P.; Leonardi, A. 1985: New 2,4-dibromo-6-(N-cyclohexyl-N-methyl)-aminomethylanilides of derivatives of cysteine and cystine with expectorant activity Il Farmaco; Edizione Scientifica 40(2): 108-119
Kirkiacharian, S.; Alaoui, M.A.; Ouidren, M.; Gayral, P. 1996: Synthesis and antiparasitic activity of new N-alkyl derivatives of 1-(nitrophenyl)-3-(methyl-3-indolyl)-prop-2-ene-1-ones (nitroindolylchalcones) Annales Pharmaceutiques Francaises 54(6): 272-275
Boido, A.; Novelli, F.; Savelli, F.; Sparatore, F.; Russo, S.; Filippelli, W.; Susanna, V.; Marmo, E. 1989: Preparation and pharmacologic activity of amido- derivatives of 3-methyl-3,4-dihydro benzo- and pyrido-1,2,4-triazin-3-acetic acids Farmaco 44(3): 279-301
Kato, T.; Suzumura, Y.; Fukushima, M.; Honda, T.; Nakanishi, T.; Noguchi, T. 1988: Antitumor activity of novel ailanthone derivatives in vitro and in vivo Anticancer Research 8(4): 573-579
Alapati, V.; Noolvi, M.N.; Manjula, S.N.; Pallavi, K.J.; Patel, H.M.; Tippeswamy, B.S.; Satyanarayana, S.V. 2012: In vivo anti-tumour activity of novel Quinazoline derivatives European Review for Medical and Pharmacological Sciences 16(13): 1753-1764
Ferko, A.P. 1972: Some cardiac effects of 1-allyl-2-benzyl-piperidine hc1, in vitro and in vivo Archives Internationales de Pharmacodynamie et de Therapie 196(2): 363-375
Kossakowski, J.; Zawadowski, T.; Kuśmierczyk, J. 1998: Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity Acta Poloniae Pharmaceutica 55(4): 315-318
Carpi, C.; Maggi, G.C. 1968: In vivo anihistidine-decarboxylasic activity of 2-methyl-6,7-methylendioxy-8-methoxy-1-(4', 5', 6',-triothoxy-7-aminophthalidyl)-1,2,3,4 tetrahydroisoquinoline (tritoqualine) Bollettino della Societa Italiana di Biologia Sperimentale 44(6): 543-546
Zaremba, M.; Borowski, J.; Feliński, J.; Rozkiewicz, D.; Rozkiewicz, M.; Zaremba, K.; Czerwiński, A.; Borowski, E. 1989: N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone Journal of ChemoTherapy 1(4 Suppl): 243-245
Albrecht, B.; Bräuniger, H. 1972: Formation of heterocyclic derivatives from (2- or 3-methyl-phenothiazinyl-(10))-propionic acid. 17. Phenothiazine derivatives Die Pharmazie 27(5): 282-287
Lukasiak, J.; Radecki, A.; Jamrógiewicz, Z. 1977: Silicone derivatives of medicinal agents. XI. Methylsilyl derivatives of methyl and propyl p-hydroxybenzoate Acta Poloniae Pharmaceutica 34(6): 615-620
Gukovskaia, A.S.; Nekrasova, G.V.; Chervin, I.I.; Sukhorukov, B.I.; Antonvskiĭ, V.L. 1973: Stacking interaction of nitrous heterocycles. Association in aqueous solutions of 6,9-dimethyladenine, 1-methyl-4-methylaminopyrazolo(3,4-d)pyrimidine and their mixtures with methyl derivatives of uracil and cytosine Biofizika 18(2): 382-384
Sánchez-Alonso, R.M.; Raviña, E.; Santana, L.; García-Mera, G.; Sanmartín, M.; Baltar, P. 1989: Piperazine derivatives of benzimidazole as potential anthelmintics. Part 1: Synthesis and activity of methyl-5-(4-substituted piperazin-1-yl)benzimidazole-2-carbamates Die Pharmazie 44(9): 606-607
Bara, A.; Socaciu, C.; Silvestru, C.; Haiduc, I. 1991: Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor Anticancer Research 11(4): 1651-1655
Zimmerman, D.M.; Leander, J.D.; Reel, J.K.; Hynes, M.D. 1987: Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands Journal of Pharmacology and Experimental Therapeutics 241(2): 374-378
Slabnov, I.D.; Cherepnev, G.V.; Tsibul'kin, A.P.; Karimova, F.G.; Garaev, R.S. 1998: The effect of pyrimidine derivatives on the sulfhydryl status of immunocompetent cells in vivo: the interrelationship with Ca2(+)-ATPase and antimutagenic activity Eksperimental'naia i Klinicheskaia Farmakologiia 61(1): 40-43
Mosberg, H.I.; Heyl, D.L.; Haaseth, R.C.; Omnaas, J.R.; Medzihradsky, F.; Smith, C.B. 1990: Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity Molecular Pharmacology 38(6): 924-928
Rao, D.V.; Rao, V.V.R.; Raghunanda, P. 1985: Studies on embelin part iii. synthesis and biological activity of some anthranilic acid ester derivatives of embelin and embelin di o methyl ether Indian Journal of Chemistry. Sect. B 24(9): 988-991
Robinson, S.P.; Koch, R.; Jordan, V.C. 1988: In vitro estrogenic actions in rat and human cells of hydroxylated derivatives of D16726 (zindoxifene), an agent with known antimammary cancer activity in vivo Cancer Research 48(4): 784-787